$$MultiPurposeText$$
Weekly semaglutide or tirzepatide injections tailored with medical oversight and lifestyle support.
A once-weekly Semaglutide or Tirzepatide injection that supports appetite control and weight loss. Administered as part of a medically guided plan, it promotes steady progress. The result is better appetite control and consistent movement toward your goals.
$$MultiPurposeText$$
Personalized, evidence-based treatment plans monitored by medical professionals for safe results.
Certified medical team oversees dosing and progress, ensuring safety and timely adjustments during your weight loss journey.
Customized titration schedules are created based on individual response to minimize side effects and maximize results.
Weekly check-ins, nutrition guidance, and coaching reinforce habits for long-term appetite control and lifestyle change.
FDA‑supported GLP-1 and dual agonist therapies reduce hunger, slow gastric emptying, and support meaningful weight loss.
$$MultiPurposeText$$
Read testimonials from our satisfied customers
Dr Toyo has been helping me with my weight loss journey and I received the best profession...more
...more
$$MultiPurposeText$$
See our work come to life--explore the gallery!








Answers to common questions about injections, safety, results, and program expectations.
Semaglutide and tirzepatide mimic hormones that regulate appetite and blood sugar, reducing hunger and helping you eat less. Administered weekly under medical supervision, doses are adjusted to balance effectiveness and tolerability while paired with lifestyle guidance.
Candidates typically have overweight or obesity and may benefit when lifestyle changes alone were insufficient. A medical evaluation checks health status, medications, and contraindications to ensure safety, then we personalize a plan to meet your goals.
Many clients see meaningful weight loss over months, often 10% or more of body weight depending on medication and adherence. Results vary; combining injections with nutrition and exercise guidance improves outcomes and sustainability.
Common side effects include nausea, mild gastrointestinal upset, and occasional diarrhea or constipation during dose escalation. These symptoms are usually temporary and manageable by adjusting dose or pace; serious risks are rare with proper screening.
Treatment length depends on goals and response; many patients continue therapy for a year or longer to achieve and maintain weight loss. We regularly reassess benefits, labs, and side effects to guide ongoing care or discontinuation.
Injections are typically self-administered subcutaneously once weekly after staff training. Initial visits include instruction and follow-up monitoring. We provide supplies, dosing schedules, and clinical oversight to ensure safe, consistent administration.